Harry R. Trout, III
Equibles does not estimate personal net worth.
Get an email with a short summary when Enanta Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get ENTA alertsAbout Harry R. Trout, III
Harry R. Trout, III is recorded as CFO at Enanta Pharmaceuticals Inc (ENTA) since August 26, 2025. Enanta Pharmaceuticals Inc reported in an 8-K filed August 27, 2025 that Harry R. Trout, III was appointed interim principal financial officer, effective August 26, 2025. Enanta Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Enanta Pharmaceuticals Inc includes Paul Mellett (CFO), Tara L. Kieffer, Ph.D. (COO), Nathaniel S. Gardiner (General Counsel) and 4 others.
“On August 26, 2025, the Board of Directors of Enanta Pharmaceuticals, Inc. (the "Company") designated Harry R. Trout, III, Vice President, Finance of the Company, as the Company's interim principal financial officer and Kathleen ("Katie") S. Capps, CPA, Executive Director, Accounting & Controller, as the Company's interim principal accounting officer, in each case on an interim basis while Paul J. Mellett, the Company's Chief Financial and Administrative Officer, is on a medical leave of absence and until such time as Mr. Mellett is able to resume his positions as principal financial officer and principal accounting officer.”
Affiliation history
-
Current
2025-08-26–present
Company network
Leadership on record at Enanta Pharmaceuticals Inc
- Paul Mellett CFO
- Tara L. Kieffer, Ph.D. COO
- Nathaniel S. Gardiner General Counsel
- Kathleen ("Katie") S. Capps Chief Accounting Officer
- Bruce L. A. Carter Board Member
- Jay R. Luly Board Member
- Yujiro S. Hata Board Member